| The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and … H Tlaskalová-Hogenová, R Štěpánková, H Kozáková, T Hudcovic, ... Cellular & molecular immunology 8 (2), 110-120, 2011 | 849 | 2011 |
| Immunostimulatory properties and antitumor activities of glucans L Vannucci, J Krizan, P Sima, D Stakheev, F Caja, L Rajsiglova, V Horak, ... International journal of oncology 43 (2), 357-364, 2013 | 265 | 2013 |
| Beta glucan: supplement or drug? From laboratory to clinical trials V Vetvicka, L Vannucci, P Sima, J Richter Molecules 24 (7), 1251, 2019 | 185 | 2019 |
| A 5-to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. F Michelassi, GE Block, L Vannucci, A Montag, R Chappell Annals of surgery 208 (3), 379, 1988 | 166 | 1988 |
| Local recurrence after curative resection of colorectal adenocarcinoma. F Michelassi, L Vannucci, JJ Ayala, R Chappel, R Goldberg, GE Block Surgery 108 (4), 787-92; discussion 792, 1990 | 165 | 1990 |
| β-glucans and cholesterol P Sima, L Vannucci, V Vetvicka International journal of molecular medicine 41 (4), 1799-1808, 2018 | 164 | 2018 |
| Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity L Vannucci, R Stepankova, H Kozakova, A Fiserova, P Rossmann, ... International journal of oncology 32 (3), 609-617, 2008 | 162 | 2008 |
| The effects of β–glucan on fish immunity V Vetvicka, L Vannucci, P Sima North American journal of medical sciences 5 (10), 580, 2013 | 140 | 2013 |
| Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo Erratum in/ijo/44/4/1410 L Vannucci, A Fiserová, K Sadalapure, TK Lindhorst, M Kuldová, ... International journal of oncology 23 (2), 285-296, 2003 | 121 | 2003 |
| Inflammation as target in cancer therapy G Marelli, A Sica, L Vannucci, P Allavena Current opinion in pharmacology 35, 57-65, 2017 | 109 | 2017 |
| Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles L Vannucci, E Falvo, M Fornara, P Di Micco, O Benada, J Krizan, ... International journal of nanomedicine, 1489-1509, 2012 | 105 | 2012 |
| Anticoagulant drugs increase natural killer cell activity in lung cancer V Bobek, M Boubelik, A Fišerová, M L’uptovcova, L Vannucci, G Kacprzak, ... Lung Cancer 47 (2), 215-223, 2005 | 77 | 2005 |
| New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity LF Castaño, V Cuartas, A Bernal, A Insuasty, J Guzman, O Vidal, V Rubio, ... European journal of medicinal chemistry 176, 50-60, 2019 | 70 | 2019 |
| TGFβ: A player on multiple fronts in the tumor microenvironment F Caja, L Vannucci Journal of immunotoxicology 12 (3), 300-307, 2015 | 67 | 2015 |
| Atherosclerosis as autoimmune disease P Sima, L Vannucci, V Vetvicka Annals of Translational Medicine 6 (7), 2018 | 63 | 2018 |
| β‐glucan as a new tool in vaccine development V Vetvicka, L Vannucci, P Sima Scandinavian Journal of Immunology 91 (2), e12833, 2020 | 59 | 2020 |
| Celiac disease and gluten-free diet: past, present, and future P Makovicky, P Makovicky, F Caja, K Rimarova, G Samasca, L Vannucci Gastroenterology and hepatology from bed to bench 13 (1), 1, 2020 | 57 | 2020 |
| The effects of β-glucan on pig growth and immunity V Vetvicka, L Vannucci, P Sima The open biochemistry journal 8, 89, 2014 | 56 | 2014 |
| Microbiome and colorectal carcinoma: insights from germ-free and conventional animal models H Tlaskalova-Hogenova, L Vannucci, K Klimesova, R Stepankova, ... The Cancer Journal 20 (3), 217-224, 2014 | 54 | 2014 |
| Stroma as an active player in the development of the tumor microenvironment L Vannucci Cancer Microenvironment 8, 159-166, 2015 | 53 | 2015 |
